In rodent studies, retatrutride has been shown to induce greater weight loss in obese mice compared to tirzepatide (8)
Microdosing Semaglutide involves administering lower doses than those used for significant weight loss, allowing for mild appetite suppression and metabolic support without drastic reductions in body weight
Diabetes can cause the nitration of GLP-1 receptors, leading to pericyte dysfunction and loss of cerebrovascular integrity
The post-marketing safety surveillance provides a level of real-world confidence that no amount of clinical trial data can replicate
According to Association for the Study of Obesity data, around 90% of weight-loss medication users access Mounjaro privately and, therefore, rely on independent providers for guidance and support when making choices that have been impacted or influenced by the cost increases in recent times 2
21 Given this critical findings, The ADA advises using GLP-1 RAs to treat type 2 diabetes in adults with MASH, citing histological benefits demonstrated in the mentioned phase 2 randomized controlled trials
